Skip to Content

93 7219 (Topiramate 100 mg)

This pill with imprint "93 7219" is Yellow, Capsule-shape and has been identified as Topiramate 100 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; lennox-gastaut syndrome (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 100 mg 93 7219
Topiramate 100 mg 93 7219
Topiramate 100 mg 93 7219

Topiramate

Imprint:
93 7219
Strength:
100 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
hypromelloses
polydextrose
ferric oxide yellow
ferrosoferric oxide
Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
68071-0813 Nucare Pharmaceuticals Inc (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide